Technology News and Research

RSS

Findings of 2009 Project Resource Management Survey released

Cognitive Technologies – a consulting firm specializing in project management, collaborative processes, and organizational effectiveness for the federal government and Fortune 1000 companies – today released the findings of its 2009 Project Resource Management Survey®, which reveals how resource management tools and processes are being used in organizations across the United States.

23 Sep 2009

St. Jude Medical's cardiovascular healthcare portfolio to be presented at TCT meeting

St. Jude Medical, Inc. (NYSE:STJ) today announced it will display products and technologies from the company’s portfolio of solutions for cardiovascular healthcare professionals at the 21st annual Transcatheter Cardiovascular Therapeutics meeting in San Francisco. The featured products reflect the company’s continued commitment to developing comprehensive, high-performance solutions which advance the practice of interventional cardiology by improving efficiencies and giving physicians more control.

23 Sep 2009

Pathway Medical's Jetstream G2 NXT catheter boosts its growth by 172 percent over the last two quarters

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced a 172 percent growth over the last two quarters with its Jetstream peripheral revascularization catheters at more than 150 centers of excellence in the United States.

23 Sep 2009

Revolution Medical's MRI software suit to be launched at RSNA annual meeting

Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it will debut its evolutionary MRI software suite at the Radiological Society of North America (RSNA) annual meeting at McCormick Place in Chicago on November 29th - December 4th.

23 Sep 2009

Institutional investors offer 50 million for Spectrum Pharmaceuticals

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a focus primarily in oncology, today announced that it has received $50 million from existing institutional investors in a previously announced registered direct offering.

23 Sep 2009

Bioscreen Instruments to be Labcyte's partner in India

Labcyte, the developer of acoustic liquid transfer, with systems in all top 10 pharmaceutical companies, today announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India.

23 Sep 2009

HRI offers in-house data resources on subscription basis

Health Research International, a leading medical products consulting firm, is pleased to announce the availability of several of its proprietary in-house data resources on a subscription basis.

23 Sep 2009

Medifacts awarded a $1.9M contract to provide cardiac safety services

MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiac diagnostic services, today announced the award of a $1.9 million contract with a Global pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large late stage clinical trial.

23 Sep 2009

Research reveals balancing act between sugar-coated nanoparticles

A research team at the National Institute of Standards and Technology (NIST) studying sugar-coated nanoparticles for use as a possible cancer therapy has uncovered a delicate balancing act that makes the particles more effective than conventional thinking says they should be. Just like individuals in a crowd respecting other people's personal space, the particles work because they get close together, but not too close.

23 Sep 2009

SEA technology to increase potency of monoclonal antibodies

Seattle Genetics, Inc. announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through enhanced effector function. The technology will be presented today by Dennis Benjamin, Ph.D., Senior Director, Chemistry, during the Americas Antibody Congress being held in Washington, DC.

23 Sep 2009

Preclinical data on Protalix Biotherapeutics' antiTNF released

Protalix Biotherapeutics, Inc., reported today preclinical data on pr-antiTNF, a biosimilar version of etanercept (Enbrel). Produced using the Company’s proprietary ProCellEx technology, pr-antiTNF is a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR), fused to the Fc component of a human antibody IgG1 domain. Pr-antiTNF has an identical amino acid sequence to Enbrel.

23 Sep 2009

Practice Fusion’s EHR offered to BioReference physicians

Practice Fusion Inc., the fastest growing electronic health record community for physicians in the United States, today announced a partnership with BioReference Laboratories, Inc. (NASDAQ:BRLI), the third largest full service laboratory in the country. The companies will collaborate to distribute Practice Fusion’s EHR to interested BioReference physicians and will integrate BioReference lab results into the Practice Fusion’s system.

23 Sep 2009

Making ACOs a permanent part of health reform will help control costs: CAPG

Leaders from California’s physicians groups are in Washington DC this week meeting with key members of Congress to offer their experience at the forefront of a key health care reform element – Accountable Care Organizations (ACOs).

23 Sep 2009

Proposed cuts can impact Ohio's health care services

The health reform bill currently pending in the House of Representatives, combined with the impact of the cuts being waved in front of Medicare-funded nursing homes -- an estimated $12 billion over 10 years -- will find Ohio's seniors in need of nursing and rehabilitative care on shaky ground.

23 Sep 2009

Bio-Path Holdings to develop liposome tumor targeting technology

Bio-Path Holdings, Inc. (OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today the Company has executed an exclusive license with The University of Texas M. D. Anderson Cancer Center to develop liposome tumor targeting technology. Bio-Path is currently developing a neutral-lipid based liposome delivery technology for nucleic acid cancer drugs (including antisense and siRNA molecules).

23 Sep 2009

Community Hospital South implements GE Healthcare's Centricity Enterprise solution

GE Healthcare, a leading provider of healthcare information technology, announced Community Hospital South (Indianapolis) is now live with GE Centricity™ Enterprise 6.1 and Monitored Care, an integrated clinical, financial and administrative solution that helps streamline workflow and improve productivity across the continuum of care.

23 Sep 2009

Researching the causes of Alzheimer's disease

The standard explanation for what causes Alzheimer's is known as the amyloid hypothesis, which posits that the disease results from of an accumulation of the peptide amyloid beta, the toxic protein fragments that deposit in the brain and become the sticky plaques that have defined Alzheimer's for more than 100 years.

23 Sep 2009

Sterile cord blood collection bag now from PacifiCord

Dedicated to serving the private cord blood banking needs of Southern California, PacifiCord (www.pacificord.com) today announced it has secured Pall Corporation’s sterile cord blood collection bag. Since April 2006, this industry-best sterile bag has been unavailable for purchase due to prior limiting agreements with its manufacturer; no longer.

23 Sep 2009

NIH grants $3.4M to develop tools for identification of prostate cancer using MRI

Rutgers University and two collaborators have received a $3.4 million research grant to develop tools aimed at improving the identification of prostate cancer using MRI, or magnetic resonance imaging.

23 Sep 2009

Medtronic's transcatheter valves to be presented at TCT 2009

With the promise of percutaneous treatments for patients with diseased heart valves growing, Medtronic, Inc., announced today that more presentations than ever before – at least 25 – on the company’s portfolio of unique transcatheter valves will be presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009, the world’s premier annual meeting for interventional cardiologists.

23 Sep 2009